Arkolith/Insider Trading/ETON/Form 4

Brynjelsen Sean

President & CEO, DirectorEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed May 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.8M
Net Open-Market Flow
-$3.8M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2026Sell(S)120K$31.88$3.8M834K
May 28, 2026Sell(S)148$32.67$5K834K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-018879) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML